July 14, 2020, Vol 324, No. 2, Pages 121-206
Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among RegulatorsA National Academies Report
Lawrence O. Gostin, JD; Alastair J. Wood, MD; Patricia A. Cuff, MS, MPH
JAMA. 2020;324(2):145-146. doi:10.1001/jama.2019.21793
This Viewpoint summarizes recommendations from a 2020 National Academies of Sciences, Engineering, and Medicine (NASEM) committee report on ways to improve regulatory oversight of drugs in an era of global pharmaceutical research and development.